Singlera Genomics

Singlera Genomics is a provider of liquid biopsy and cancer early detection solutions. It offers PDACatch, a liquid biopsy assay for the early detection of pancreatic adenocarcinoma; GutSeer, a noninvasive test for the early detection and localization of gastrointestinal cancers; ColonES, a blood-based screening solution for colorectal cancer detection; and ColonAiQ, a multi-locus blood-based assay targeting circulating tumor DNA methylation. The company also develops liquid biopsy assays for personalized minimal residual disease and point-of-care testing kits.